Heartland Group Holdings
- Short interest
- 0.04%
- −0.10 pp 30d
- as of 4 Feb 2025
- Reported shorts
- 380.9K
- Shares on issue
- 937.419M
Heartland Group Holdings (HGH) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in NZD, the reporting currency
- Revenue
- 367.6MM (source: ASX (Markit))vs 319.1M (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- 93.2MM (source: ASX (Markit))vs 38.8M (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- 0.099T (source: Derived: trailing 12 months at year end)vs 0.041 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- +15.2%FY
- EPS YoY
- +138.9%TTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of HGH publishes Annual Report, Climate Statement, AGM date, 29 Sep 2026
Heartland reported statutory net profit after tax of $93.2 million for FY2026, up from $38.8 million in FY2025, with underlying NPAT of $90.4 million (up from $46.9 million). The company did not declare a dividend in this report. Guidance for FY2027 focuses on sustainable growth and improved shareholder returns, with the proposed TSB acquisition pending shareholder and regulatory approvals.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 15 Oct 2026
- Gross margin
- n/m
- Operating margin
- n/m
- Net margin
- 25.4%
- FCF margin
- n/m
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/m
- Net debt (excl. leases)
- n/m
- Net debt / EBITDA
- n/m
- Current ratio
- n/m
- Interest cover
- n/m
- Cash dividends paid / net profit
- 47.6%
- Market cap
- n/a
- P/E
- n/a (reports in NZD)
- P/B
- n/a (reports in NZD)
n/m: not meaningful for banks, insurers and other financials.
Ratios use the reporting currency (NZD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in NZD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | 367.6MM (source: ASX (Markit)) | 319.1M | 288.5M | 282.1M |
| Interest expense | 326.7MT (source: Derived: trailing 12 months at year end) | 398.6M | 383.4M | 245.7M |
| Pretax income | 132.4MT (source: Derived: trailing 12 months at year end) | 57.2M | 104.5M | 134.0M |
| Tax | 39.2MT (source: Derived: trailing 12 months at year end) | 18.4M | 30.0M | 38.1M |
| NPAT | 93.2MM (source: ASX (Markit)) | 38.8M | 74.5M | 95.9M |
| Net interest income | 337.9MT (source: Derived: trailing 12 months at year end) | 307.3M | 277.6M | 282.0M |
| EPS basic | 0.099T (source: Derived: trailing 12 months at year end) | 0.041 | 0.099 | 0.14 |
| EPS diluted | 0.099T (source: Derived: trailing 12 months at year end) | 0.041 | 0.099 | 0.14 |
| Shares | n/a | 940.6M | 931.0M | 732.9M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- HGH publishes Annual Report, Climate Statement, AGM dateAnnual Report29 Sep 2026via asx_announcements
- Half Year AccountsHalf Year Results26 Feb 2026via asx_announcements
- Half year results announcement dateHalf Year Results28 Jan 2026via asx_announcements
- Annual Report to shareholdersAnnual Report30 Sep 2025via asx_announcements
- Half year results announcement dateHalf Year Results30 Jan 2025via asx_announcements
- Annual Report to shareholdersAnnual Report30 Sep 2024via asx_announcements
- Half Year AccountsHalf Year Results27 Feb 2024via asx_announcements
- Half year results announcement dateHalf Year Results30 Jan 2024via asx_announcements